Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor

被引:0
|
作者
Gui-xia Liu
Jin-zhi Tan
Chun-ying Niu
Jian-hua Shen
Xiao-min Luo
Xu Shen
Kai-xian Chen
Hua-liang Jiang
机构
[1] Center for Drug Discovery and Design,
[2] State Key Laboratory of Drug Research,undefined
[3] Shanghai Institute of Materia Medica,undefined
[4] Shanghai Institutes for Biological Sciences,undefined
[5] Chinese Academy of Sciences,undefined
[6] School of Pharmacy,undefined
[7] East China University of Science and Technology,undefined
来源
关键词
molecular dynamics simulation; principal component analysis; protein-tyrosine phosphatase 1B; type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:100 / 110
页数:10
相关论文
共 50 条
  • [21] Protein-tyrosine phosphatase 1B (PTP1B) as a therapeutic target in glioblastoma
    Bartolome, Ruben
    Jaen, Marta
    Burdiel, Miranda
    Balyasnikova, Irina V.
    Casal, Ignacio
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors
    Murthy, VS
    Kulkarni, VM
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (04) : 897 - 906
  • [23] Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations
    Yan, Fangfang
    Liu, Xinguo
    Zhang, Shaolong
    Su, Jing
    Zhang, Qinggang
    Chen, Jianzhong
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (14): : 3636 - 3650
  • [24] Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B
    Iversen, LF
    Andersen, HS
    Branner, S
    Mortensen, SB
    Peters, GH
    Norris, K
    Olsen, OH
    Jeppesen, CB
    Lundt, BF
    Ripka, W
    Moller, KB
    Moller, NPH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) : 10300 - 10307
  • [25] The mode of action of the Protein tyrosine phosphatase 1B inhibitor Ertiprotafib
    Kumar, Ganesan Senthil
    Page, Rebecca
    Peti, Wolfgang
    PLOS ONE, 2020, 15 (10):
  • [26] Regulation of the Met Receptor-tyrosine Kinase by the Protein-tyrosine Phosphatase 1B and T-cell Phosphatase
    Sangwan, Veena
    Paliouras, Grigorios N.
    Abella, Jasmine V.
    Dube, Nadia
    Monast, Anie
    Tremblay, Michel L.
    Park, Morag
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (49) : 34374 - 34383
  • [27] Synthesis and biological evaluation of α,α-difluorobenzylphosphonic acid derivatives as small molecular inhibitors of protein-tyrosine phosphatase 1B
    Yokomatsu, T
    Murano, T
    Umesue, I
    Soeda, S
    Shimeno, H
    Shibuya, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (04) : 529 - 532
  • [28] Disruption of Protein-Tyrosine Phosphatase 1B Expression in the Pancreas Affects β-Cell Function
    Liu, Siming
    Xi, Yannan
    Bettaieb, Ahmed
    Matsuo, Kosuke
    Matsuo, Izumi
    Kulkarni, Rohit N.
    Haj, Fawaz G.
    ENDOCRINOLOGY, 2014, 155 (09) : 3329 - 3338
  • [29] Calpain-mediated degradation of reversibly oxidized protein-tyrosine phosphatase 1B
    Truempler, Antje
    Schlott, Bernhard
    Herrlich, Peter
    Greer, Peter A.
    Boehmer, Frank-D.
    FEBS JOURNAL, 2009, 276 (19) : 5622 - 5633
  • [30] Structure-based design of protein-tyrosine phosphatase 1B inhibitors.
    Burke, TR
    Yao, ZJ
    Ye, B
    Wang, SM
    Zhang, ZY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 313 - MEDI